Why the study?
Does bradykinin pretreatment improve postischaemic functional recovery in isolated rat hearts?
Does bradykinin pretreatment improve postischaemic functional recovery in isolated rat hearts?
Bradykinin protects against postischaemic contractile dysfunction via B2-receptors to a similar extent as ischaemic preconditioning, though B2-receptors do not appear to mediate the ischaemic preconditioning phenomenon itself.
Answers are grounded in this paper and cite their sources.
Bradykinin may mimic preconditioning-like protection in isolated rat hearts; hypothesis-generating for B2-agonism with no clinical implications yet.
OBJECTIVES: Substantial release of bradykinin has been demonstrated to occur during short periods of myocardial ischaemia in various species. The aim of the present study was to investigate the protective effect of bradykinin in ischaemia and whether bradykinin could be involved in ischaemic preconditioning in the rat heart. METHODS: Isolated, buffer-perfused hearts were subjected to 30 min of global ischaemia, followed by 30 min of reperfusion. Postischaemic functional recovery was recorded in the following groups: (1) control; (2) treatment with 0.1 microM bradykinin for 10 min before ischaemia (BK); (3) bradykinin treatment combined with pretreatment with the specific bradykinin B2-receptor antagonist, HOE 140; (4) ischaemic preconditioning by 5 min ischaemia +5 min reperfusion prior to sustained ischaemia (i.p.); and (5) ischaemic preconditioning combined with HOE 140 administration. RESULTS: Postischaemic myocardial function was significantly improved in both BK and i.p. groups (developed pressure 66.9 +/- 6.8 and 67.6 +/- 7.1 mmHg, respectively, vs. 43.1 +/- 5.9 mmHg in controls, P < 0.05). Pretreatment with 1 microM HOE 140 completely abolished the effect of bradykinin, while protection achieved by i.p. was unaltered by this drug. None of the protective interventions was associated with any significant improvement in myocardial adenosine triphosphate, creatine phosphate, glycogen, lactate or glucose tissue levels, detected either at the end of ischaemia or after 30 min of reperfusion. CONCLUSIONS: Bradykinin, acting via B2-receptors, can protect against postischaemic contractile dysfunction to a similar extent as i.p.. An involvement of B2-receptors in the ischaemic preconditioning phenomenon could, however, not be demonstrated.
No takes yet. Share an insight, caveat, or question.
Joel Starkopf (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: